[1] Porter, T.D. and Coon, M.J. (1991) Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. Journal of Biological Chemistry, 266, 13469-13472.
[2] Pollock, B.G. (1994) Recent developments in drug metabolism of relevance to psychiatrists. Harvard Review of Psychiatry, 2, 204-213. doi:10.3109/10673229409017138
[3] Ball, S.E., Maurer, G., Zollinger, M., Ladona, M. and Vicker, A.E. (1992) Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans. Drug Metabolism and Disposition, 20, 56-63.
[4] Moochhala, S.M., Lee, E.J., Hu, G.T., Koh, O.S. and Becket, G. (1989) Effects of bromocryptine on hepatic cytochrome P-450 monooxygenase system. Japanese Journal of Pharmacology, 49, 285-291. doi:10.1254/jjp.49.285
[5] Witkamp, R.F., Nijmeijer, S.M., Monshouwer, M. and Van Miert, A.S. (1995) The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig. Drug Metabolism and Disposition, 23, 542- 547.
[6] Moubarak A.S., Rosenkrans, C.F. Jr. and Johnson, Z.B. (2003) Modulation of Cytochrome P450 Metabolism by Ergonovine and Dihydroergotamine. Veterinary & Human Toxicology, 45, 6-9.
[7] Strickland, J.R, Cross, D.L, Jenkins, T.C., Petroski, R.J. and Powell, R.G (1992) The effect of alkaloids and seed extracts of endophyte-infected tall fescue on prolactin secretion in an in vitro rat pituitary perfusion system. Journal of Animal Science, 70, 2779-2786.